CNTA logo

Centessa Pharmaceuticals plc (CNTA) EBIT

Annual EBIT:

-$201.14M-$29.19M(-16.98%)
December 31, 2024

Summary

  • As of today, CNTA annual earnings before interest & taxes is -$201.14 million, with the most recent change of -$29.19 million (-16.98%) on December 31, 2024.
  • During the last 3 years, CNTA annual EBIT has fallen by -$61.83 million (-44.38%).
  • CNTA annual EBIT is now -6258.34% below its all-time high of -$3.16 million, reached on December 31, 2020.

Performance

CNTA EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCNTAincome statement metrics

Quarterly EBIT:

-$55.30M-$24.40M(-78.99%)
June 1, 2025

Summary

  • As of today, CNTA quarterly earnings before interest & taxes is -$55.30 million, with the most recent change of -$24.40 million (-78.99%) on June 1, 2025.
  • Over the past year, CNTA quarterly EBIT has dropped by -$11.27 million (-25.60%).
  • CNTA quarterly EBIT is now -291.22% below its all-time high of $28.92 million, reached on December 1, 2020.

Performance

CNTA Quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCNTAincome statement metrics

TTM EBIT:

-$206.96M-$11.27M(-5.76%)
June 1, 2025

Summary

  • As of today, CNTA TTM earnings before interest & taxes is -$206.96 million, with the most recent change of -$11.27 million (-5.76%) on June 1, 2025.
  • Over the past year, CNTA TTM EBIT has dropped by -$51.41 million (-33.05%).
  • CNTA TTM EBIT is now -815.64% below its all-time high of $28.92 million, reached on December 1, 2020.

Performance

CNTA TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCNTAincome statement metrics

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

CNTA EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-17.0%-25.6%-33.0%
3Y3 Years-44.4%+18.5%+2.2%
5Y5 Years-3969.2%-291.2%-815.6%

CNTA EBIT Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-44.4%+4.3%-79.0%+25.2%-33.0%+6.8%
5Y5-Year-6258.3%+4.3%-291.2%+25.2%-815.6%+6.8%
All-TimeAll-Time-6258.3%+4.3%-291.2%+25.2%-815.6%+6.8%

CNTA EBIT History

DateAnnualQuarterlyTTM
Jun 2025
-
-$55.30M(-79.0%)
-$206.96M(-5.8%)
Mar 2025
-
-$30.90M(+58.2%)
-$195.69M(+2.6%)
Dec 2024
-$201.14M(-17.0%)
-$73.89M(-57.6%)
-$200.87M(-23.6%)
Sep 2024
-
-$46.88M(-6.5%)
-$162.46M(-4.4%)
Jun 2024
-
-$44.03M(-22.1%)
-$155.56M(+2.0%)
Mar 2024
-
-$36.07M(-1.6%)
-$158.70M(+7.7%)
Dec 2023
-$171.95M(+18.2%)
-$35.48M(+11.2%)
-$171.95M(+3.6%)
Sep 2023
-
-$39.98M(+15.3%)
-$178.38M(+4.6%)
Jun 2023
-
-$47.17M(+4.4%)
-$187.02M(+9.9%)
Mar 2023
-
-$49.32M(-17.7%)
-$207.66M(+0.8%)
DateAnnualQuarterlyTTM
Dec 2022
-$210.15M(-50.8%)
-$41.91M(+13.8%)
-$209.29M(+5.7%)
Sep 2022
-
-$48.61M(+28.3%)
-$222.02M(-4.9%)
Jun 2022
-
-$67.82M(-33.1%)
-$211.56M(-21.8%)
Mar 2022
-
-$50.94M(+6.8%)
-$173.65M(-22.5%)
Dec 2021
-$139.31M(-4303.9%)
-$54.65M(-43.3%)
-$141.73M(-143.7%)
Sep 2021
-
-$38.14M(-27.5%)
-$58.16M(-190.5%)
Jun 2021
-
-$29.92M(-57.3%)
-$20.02M(-302.2%)
Mar 2021
-
-$19.02M(-165.8%)
$9.90M(-65.8%)
Dec 2020
-$3.16M(+36.0%)
-
-
Dec 2020
-
$28.92M
$28.92M
Dec 2019
-$4.94M
-
-

FAQ

  • What is Centessa Pharmaceuticals plc annual earnings before interest & taxes?
  • What is the all-time high annual EBIT for Centessa Pharmaceuticals plc?
  • What is Centessa Pharmaceuticals plc annual EBIT year-on-year change?
  • What is Centessa Pharmaceuticals plc quarterly earnings before interest & taxes?
  • What is the all-time high quarterly EBIT for Centessa Pharmaceuticals plc?
  • What is Centessa Pharmaceuticals plc quarterly EBIT year-on-year change?
  • What is Centessa Pharmaceuticals plc TTM earnings before interest & taxes?
  • What is the all-time high TTM EBIT for Centessa Pharmaceuticals plc?
  • What is Centessa Pharmaceuticals plc TTM EBIT year-on-year change?

What is Centessa Pharmaceuticals plc annual earnings before interest & taxes?

The current annual EBIT of CNTA is -$201.14M

What is the all-time high annual EBIT for Centessa Pharmaceuticals plc?

Centessa Pharmaceuticals plc all-time high annual earnings before interest & taxes is -$3.16M

What is Centessa Pharmaceuticals plc annual EBIT year-on-year change?

Over the past year, CNTA annual earnings before interest & taxes has changed by -$29.19M (-16.98%)

What is Centessa Pharmaceuticals plc quarterly earnings before interest & taxes?

The current quarterly EBIT of CNTA is -$55.30M

What is the all-time high quarterly EBIT for Centessa Pharmaceuticals plc?

Centessa Pharmaceuticals plc all-time high quarterly earnings before interest & taxes is $28.92M

What is Centessa Pharmaceuticals plc quarterly EBIT year-on-year change?

Over the past year, CNTA quarterly earnings before interest & taxes has changed by -$11.27M (-25.60%)

What is Centessa Pharmaceuticals plc TTM earnings before interest & taxes?

The current TTM EBIT of CNTA is -$206.96M

What is the all-time high TTM EBIT for Centessa Pharmaceuticals plc?

Centessa Pharmaceuticals plc all-time high TTM earnings before interest & taxes is $28.92M

What is Centessa Pharmaceuticals plc TTM EBIT year-on-year change?

Over the past year, CNTA TTM earnings before interest & taxes has changed by -$51.41M (-33.05%)
On this page